Vical Incorporated today announced the release to television news stations nationwide of an independently produced video report featuring metastatic melanoma patients treated with the company's Allovectin-7® immunotherapeutic product candidate.
Discuss
Add this link to...
Tell a friend
Bury
Discuss
Add this link to...
Tell a friend
Bury
FCC.com is the place for all news and information regarding the Federal Communications Commission. Vote for your favorite stories, or become a member to submit stories.
Comments